drugset / Trial / NCT02188407

Inflammation After One Lung Ventilation

NCT02188407

Phase 1 Completed 40 enrolled University Medical Centre Ljubljana
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study was to prospectively investigate the influence of one-lung ventilation (OLV) on the inflammatory response and to identify possible antiinflammatory effects of the volatile anaesthetic sevoflurane. Forty patients undergoing thoracic surgery with OLV were enrolled in this prospective, randomised study. The patients were randomly allocated into two groups to receive either propofol (Group P) or sevoflurane (Group S) for induction and maintenance of anaesthesia. Inflammatory mediators (Interleukin 6 (IL6), Interleukin8 (IL8), Interleukin 10 (IL10), (C- reactive protein)CRP) were measured intra- and postoperatively. Six hours after surgery oxygenation index (PaO2/FiO2) was calculated and chest X ray was taken and assessed. The clinical outcome determinated by postoperative adverse events was assessed as the secondary endpoint.

Timeline

Start
2008-07
Primary completion
2013-09
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 4 mg/kg
Comparator Propofol Small molecule 6 mg/kg
Subject Sevoflurane Other / unclassified 3 %
Subject Sevoflurane Other / unclassified 5 %

Indications

No indication recorded.